Types of arthritis

Reading File
Finding Sources
Searching Images

types of arthritis comparison joint changes

Educational comparison diagrams illustrating musculoskeletal changes in inflammatory arthritis. (a) A comparative anatomical diagram of a normal hand versus a hand with Rheumatoid Arthritis (RA). The normal hand shows clear joint spaces and smooth bone alignment. The RA hand depicts ulnar deviation, swelling of the metacarpophalangeal and interphalangeal joints, and joint space narrowing. Inset circles provide a high-magnification view of a healthy synovial joint versus an RA joint characterized by cartilage erosion and synovial inflammation (pannus). (b) A sagittal anatomical illustration of the head, neck, and upper torso highlighting changes associated with Ankylosing Spondylitis (AS). The cervical spine (green) and thoracic spine (orange) show indicative features of syndesmophyte formation and vertebral fusion, leading to a loss of the normal physiological curvature and the development of a 'bamboo spine' appearance. These visuals are intended to demonstrate the distinctive clinical manifestations and progressive joint degradation found in chronic rheumatological conditions.

Educational comparison diagrams illustrating musculoskeletal changes in inflammatory arthritis. (a) A comparative anatomical diagram of a normal hand versus a hand with Rheumatoid Arthritis (RA). The normal hand shows clear joint spaces and smooth bone alignment. The RA hand depicts ulnar deviation, swelling of the metacarpophalangeal and interphalangeal joints, and joint space narrowing. Inset circles provide a high-magnification view of a healthy synovial joint versus an RA joint characterized by cartilage erosion and synovial inflammation (pannus). (b) A sagittal anatomical illustration of the head, neck, and upper torso highlighting changes associated with Ankylosing Spondylitis (AS). The cervical spine (green) and thoracic spine (orange) show indicative features of syndesmophyte formation and vertebral fusion, leading to a loss of the normal physiological curvature and the development of a 'bamboo spine' appearance. These visuals are intended to demonstrate the distinctive clinical manifestations and progressive joint degradation found in chronic rheumatological conditions.

Comparison of delayed Gadolinium-Enhanced Magnetic Resonance Imaging (dGEMRIC) maps of the third metacarpophalangeal (MCP3) joint, illustrating cartilage composition changes in a patient with early rheumatoid arthritis. The image displays a side-by-side comparison of 'baseline' and 'follow-up' (24 weeks post-adalimumab plus methotrexate therapy) states, fused with morphological MRI scans. A color-coded scale on the left represents dGEMRIC values in milliseconds (ms), where blue/purple indicate low glycosaminoglycan (GAG) content (cartilage damage) and red/yellow indicate high GAG content (healthy cartilage). At baseline, the articular cartilage is predominantly blue, signifying significant GAG depletion. At follow-up, there is a visible spatial shift toward green and red hues centrally within the joint space, indicating increased dGEMRIC values and cartilage biochemical regeneration. This imaging modality demonstrates the utility of functional MRI in monitoring pharmacological response to biologic therapy beyond simple structural assessment.

Comparison of delayed Gadolinium-Enhanced Magnetic Resonance Imaging (dGEMRIC) maps of the third metacarpophalangeal (MCP3) joint, illustrating cartilage composition changes in a patient with early rheumatoid arthritis. The image displays a side-by-side comparison of 'baseline' and 'follow-up' (24 weeks post-adalimumab plus methotrexate therapy) states, fused with morphological MRI scans. A color-coded scale on the left represents dGEMRIC values in milliseconds (ms), where blue/purple indicate low glycosaminoglycan (GAG) content (cartilage damage) and red/yellow indicate high GAG content (healthy cartilage). At baseline, the articular cartilage is predominantly blue, signifying significant GAG depletion. At follow-up, there is a visible spatial shift toward green and red hues centrally within the joint space, indicating increased dGEMRIC values and cartilage biochemical regeneration. This imaging modality demonstrates the utility of functional MRI in monitoring pharmacological response to biologic therapy beyond simple structural assessment.

This diagnostic image is a coronal T1 Turbo Spin Echo (TSE) MRI of a pediatric pelvis, illustrating musculoskeletal manifestations of Juvenile Idiopathic Arthritis (JIA). The scan provides a side-by-side comparison of the hip joints. The right hip joint exhibits significant pathological changes, including marked joint space narrowing and prominent bony erosions (indicated by white arrows) on both the superior aspect of the femoral head and the adjacent acetabular margin. These erosions appear as irregular, low-signal intensity focal concavities and lytic lesions that disrupt the smooth cortical contour. In contrast, the left hip joint maintains a relatively preserved joint space and smooth articular surfaces without evidence of bone destruction. The image demonstrates the clinical utility of MRI in detecting late-stage structural damage, such as cartilage loss and erosive disease, which are key indicators of joint destruction in chronic inflammatory arthritis. This content is intended for advanced medical education in pediatric radiology and rheumatology.

This diagnostic image is a coronal T1 Turbo Spin Echo (TSE) MRI of a pediatric pelvis, illustrating musculoskeletal manifestations of Juvenile Idiopathic Arthritis (JIA). The scan provides a side-by-side comparison of the hip joints. The right hip joint exhibits significant pathological changes, including marked joint space narrowing and prominent bony erosions (indicated by white arrows) on both the superior aspect of the femoral head and the adjacent acetabular margin. These erosions appear as irregular, low-signal intensity focal concavities and lytic lesions that disrupt the smooth cortical contour. In contrast, the left hip joint maintains a relatively preserved joint space and smooth articular surfaces without evidence of bone destruction. The image demonstrates the clinical utility of MRI in detecting late-stage structural damage, such as cartilage loss and erosive disease, which are key indicators of joint destruction in chronic inflammatory arthritis. This content is intended for advanced medical education in pediatric radiology and rheumatology.

Three-dimensional computed tomography (3D-CT) comparison of mouse knee joints in a model of erosive arthritis related to Epstein-Barr virus (EBV) infection. The figure is divided into three columns representing EBV-infected subjects (A and B) and an EBV-uninfected control (C), with multiple anatomical views for each. Column A and B display significant pathological changes in the bone architecture of humanized NOG mice. White arrowheads highlight focal bone erosions, visible as irregular pitting, cortical discontinuity, and structural breakdown at the distal femur and proximal tibia. These morphological features resemble the erosive changes seen in Rheumatoid Arthritis (RA). In contrast, column C displays the control joint, characterized by smooth, intact cortical surfaces and a preserved joint space without signs of osseous degradation. This diagnostic imaging serves to demonstrate the development of virus-induced erosive joint disease and the role of humanized immune cells in bone resorption.

Three-dimensional computed tomography (3D-CT) comparison of mouse knee joints in a model of erosive arthritis related to Epstein-Barr virus (EBV) infection. The figure is divided into three columns representing EBV-infected subjects (A and B) and an EBV-uninfected control (C), with multiple anatomical views for each. Column A and B display significant pathological changes in the bone architecture of humanized NOG mice. White arrowheads highlight focal bone erosions, visible as irregular pitting, cortical discontinuity, and structural breakdown at the distal femur and proximal tibia. These morphological features resemble the erosive changes seen in Rheumatoid Arthritis (RA). In contrast, column C displays the control joint, characterized by smooth, intact cortical surfaces and a preserved joint space without signs of osseous degradation. This diagnostic imaging serves to demonstrate the development of virus-induced erosive joint disease and the role of humanized immune cells in bone resorption.

Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have enough information to compose a thorough answer. Let me also fetch the arthritis comparison image.
Inflammatory Arthritis - RA vs Ankylosing Spondylitis

Types of Arthritis

Arthritis is not a single disease - it refers to joint inflammation and damage from many different causes. Over 100 distinct types exist, but they fall into a few major categories.

1. Degenerative Arthritis

Osteoarthritis (OA)

  • Most common form of joint disease worldwide.
  • Caused by biomechanical stress exceeding cartilage synthesis capacity - matrix breakdown is the primary driver; inflammation is minimal and secondary.
  • Local inflammatory cytokines (e.g., IL-1, TNF) contribute to progression.
  • Affects weight-bearing joints (knees, hips), spine, and hands (DIP joints, CMC joints).
  • Key features: joint space narrowing, osteophytes, subchondral sclerosis, bony crepitus.
  • No systemic features; ESR/CRP usually normal.
- Robbins & Kumar Basic Pathology, p. 805

2. Inflammatory / Autoimmune Arthritis

Rheumatoid Arthritis (RA)

  • Chronic autoimmune disease driven by cellular and humoral immune response against citrullinated proteins (anti-CCP antibodies positive in 60-80%; specificity 85-99%).
  • TNF plays a central pathogenic role; anti-TNF biologics are effective.
  • Symmetric, small-joint polyarthritis (MCPs, PIPs, wrists); spares DIP joints.
  • Hallmarks: pannus formation, synovitis, articular erosions, morning stiffness >1 hour.
  • Systemic manifestations: rheumatoid nodules, interstitial lung disease, vasculitis, pericarditis.
- Robbins & Kumar Basic Pathology; Firestein & Kelley's Textbook of Rheumatology

Juvenile Idiopathic Arthritis (JIA)

  • Arthritis onset before age 16, lasting >6 weeks, with no other identifiable cause.
  • Several subtypes: oligoarticular (most common), polyarticular (RF+ or RF-), systemic (Still disease), enthesitis-related, psoriatic.
  • Complication: uveitis (especially in ANA-positive oligoarticular JIA).

Systemic Lupus Erythematosus (SLE) - Lupus Arthritis

  • Arthritis/arthralgias occur in up to 90% of SLE patients.
  • Symmetric inflammatory arthritis, predominantly knees, wrists, and small hand joints.
  • Key feature: Jaccoud's arthropathy - reducible deformities (ulnar deviation, swan-neck) due to ligamentous laxity without typical radiographic erosions.
  • Synovial effusions are less inflammatory than in RA.
- Firestein & Kelley's Textbook of Rheumatology

3. Seronegative Spondyloarthropathies (SpA)

A heterogeneous group strongly linked to HLA-B27 (present in ~90% of ankylosing spondylitis). They preferentially involve sacroiliac and vertebral joints and share enthesitis as a unifying feature.
SubtypeKey Features
Ankylosing Spondylitis (AS)Young men; chronic low back pain/stiffness; sacroiliitis; "bamboo spine"; uveitis
Psoriatic Arthritis (PsA)Associated with psoriasis; DIP involvement; dactylitis ("sausage digit"); asymmetric
Reactive ArthritisFollows GI (Salmonella, Campylobacter) or genitourinary (Chlamydia) infection; asymmetric oligoarthritis; urethritis/conjunctivitis
IBD-associated ArthritisPeripheral (parallels bowel activity) or axial (independent of bowel disease)
Undifferentiated SpAFeatures of SpA without fitting a defined subtype
- Robbins & Kumar Basic Pathology; Kanski's Clinical Ophthalmology

4. Crystal Arthropathy

Gout

  • Caused by monosodium urate (MSU) crystal deposition in joints due to hyperuricemia.
  • Needle-shaped crystals with strong negative birefringence on polarized microscopy.
  • Classically affects the first MTP joint (podagra), ankles, and knees.
  • Acute flares + chronic tophaceous gout; urate-lowering therapy (allopurinol, febuxostat) is the long-term treatment.

Pseudogout (CPPD - Calcium Pyrophosphate Deposition Disease)

  • Caused by calcium pyrophosphate dihydrate (CPPD) crystals.
  • Rhomboid-shaped crystals with weakly positive birefringence.
  • Most common in knees and wrists.
  • Chondrocalcinosis on X-ray is characteristic.
- Tietz Textbook of Laboratory Medicine; Miller's Review of Orthopaedics

5. Infectious Arthritis

Septic (Suppurative) Arthritis

  • Bacterial infection of a joint space, usually acquired hematogenously.
  • Most common organism: Staphylococcus aureus (adults); Neisseria gonorrhoeae (sexually active young adults).
  • Medical emergency - requires joint aspiration and IV antibiotics.
  • Hot, swollen, single joint (monoarthritis); WBC in synovial fluid typically >50,000/µL.

Lyme Arthritis

  • Caused by Borrelia burgdorferi (tick-borne).
  • Oligoarthritis, especially knees, weeks to months after infection.
  • May have autoimmune component in chronic stages.
- Robbins & Kumar Basic Pathology

6. Other Notable Types

TypeKey Points
Psoriatic ArthritisListed separately above but also classified as SpA; nail changes + arthritis
Enteropathic ArthritisSeen in Crohn's and UC; peripheral or axial pattern
Hemophilic ArthropathyRecurrent hemarthrosis causing chronic joint destruction
Neuropathic (Charcot) JointProgressive joint destruction due to loss of pain sensation (diabetes, syphilis, syringomyelia)
Viral ArthritisParvovirus B19, Hepatitis B/C, HIV, Chikungunya; usually self-limiting

Quick Comparison: The Big Three

FeatureOsteoarthritisRheumatoid ArthritisGout
MechanismMechanical wearAutoimmuneCrystal deposition
Age>50 (older adults)Any age (peak 40-60)Typically men >40
Joint patternAsymmetric; DIP, knees, hipsSymmetric; MCP, PIP, wristsAsymmetric; MTP, knees
Morning stiffness<30 minutes>1 hourNot a feature
Systemic featuresNoYesNo (except tophi)
LabsNormal ESR/CRPElevated CRP/ESR, RF+, anti-CCP+Elevated uric acid
X-rayOsteophytes, sclerosisErosions, periarticular osteopeniaPunched-out erosions, tophi

The classification of arthritis matters clinically because treatment differs drastically - from simple analgesics and exercise in OA, to biologic DMARDs in RA and spondyloarthropathies, to urate-lowering therapy in gout, and urgent drainage/antibiotics in septic arthritis.

Rheumatic arthritis

Reading File
Finding Sources
Searching Images

rheumatoid arthritis joint pathology hand deformity

Clinical photographs of a hand demonstrating chronic structural deformities characteristic of rheumatoid arthritis. The upper image provides a lateral view focusing on a digit showing a prominent deformity at the proximal interphalangeal (PIP) joint and enlargement of the metacarpophalangeal (MCP) joint. The lower image provides a dorsal view of the hand, illustrating significant ulnar deviation of the fingers at the MCP joints, which is a classic hallmark of progressive inflammatory arthritis. There is visible soft tissue swelling and joint enlargement at the 2nd metacarpal and multiple PIP joints. The images exemplify the long-term musculoskeletal manifestations of active rheumatoid arthritis, showcasing joint misalignment and chronic inflammatory changes in the small joints of the hand. This content is suitable for teaching clinical signs of autoimmune rheumatological diseases and physical examination findings in hand pathology.

Clinical photographs of a hand demonstrating chronic structural deformities characteristic of rheumatoid arthritis. The upper image provides a lateral view focusing on a digit showing a prominent deformity at the proximal interphalangeal (PIP) joint and enlargement of the metacarpophalangeal (MCP) joint. The lower image provides a dorsal view of the hand, illustrating significant ulnar deviation of the fingers at the MCP joints, which is a classic hallmark of progressive inflammatory arthritis. There is visible soft tissue swelling and joint enlargement at the 2nd metacarpal and multiple PIP joints. The images exemplify the long-term musculoskeletal manifestations of active rheumatoid arthritis, showcasing joint misalignment and chronic inflammatory changes in the small joints of the hand. This content is suitable for teaching clinical signs of autoimmune rheumatological diseases and physical examination findings in hand pathology.

Clinical photograph of the dorsal aspect of bilateral hands and wrists in a patient with Rheumatoid Arthritis (RA). The image demonstrates characteristic chronic inflammatory joint deformities. On the left hand, there is a prominent swan-neck deformity of the fifth digit, characterized by hyperextension of the proximal interphalangeal (PIP) joint and flexion of the distal interphalangeal (DIP) joint. Swelling is visible across the interphalangeal joints of the third and fourth digits. The right hand shows a significant, localized soft tissue swelling on the lateral/ulnar aspect of the wrist joint, consistent with synovial hypertrophy or a rheumatoid nodule. General architectural changes include joint stiffness and minor deviations of the fingers. This visual illustrates the progressive peripheral joint involvement and resulting anatomical deformities typical of systemic inflammatory polyarthritis, emphasizing the clinical signs used in diagnosing the severity of RA.

Clinical photograph of the dorsal aspect of bilateral hands and wrists in a patient with Rheumatoid Arthritis (RA). The image demonstrates characteristic chronic inflammatory joint deformities. On the left hand, there is a prominent swan-neck deformity of the fifth digit, characterized by hyperextension of the proximal interphalangeal (PIP) joint and flexion of the distal interphalangeal (DIP) joint. Swelling is visible across the interphalangeal joints of the third and fourth digits. The right hand shows a significant, localized soft tissue swelling on the lateral/ulnar aspect of the wrist joint, consistent with synovial hypertrophy or a rheumatoid nodule. General architectural changes include joint stiffness and minor deviations of the fingers. This visual illustrates the progressive peripheral joint involvement and resulting anatomical deformities typical of systemic inflammatory polyarthritis, emphasizing the clinical signs used in diagnosing the severity of RA.

This clinical photograph displays the palmar surface of a right hand, primarily illustrating a classic 'Z-thumb' deformity (Hitchhiker thumb), a hallmark sign frequently associated with advanced rheumatoid arthritis. The deformity is characterized by severe flexion at the metacarpophalangeal (MCP) joint and compensatory hyperextension at the interphalangeal (IP) joint. There is also evident bony swelling and ulnar deviation at the wrist. While the distal interphalangeal (DIP) joints of the digits appear relatively spared, there is subtle swelling suggestive of polyarthropathy in the proximal regions. The thumb's skin shows a blue discoloration, likely from diagnostic marking or external staining. This image serves as an educational example of chronic inflammatory joint destruction and secondary ligamentous laxity leading to fixed musculoskeletal deformities in systemic autoimmune conditions.

This clinical photograph displays the palmar surface of a right hand, primarily illustrating a classic 'Z-thumb' deformity (Hitchhiker thumb), a hallmark sign frequently associated with advanced rheumatoid arthritis. The deformity is characterized by severe flexion at the metacarpophalangeal (MCP) joint and compensatory hyperextension at the interphalangeal (IP) joint. There is also evident bony swelling and ulnar deviation at the wrist. While the distal interphalangeal (DIP) joints of the digits appear relatively spared, there is subtle swelling suggestive of polyarthropathy in the proximal regions. The thumb's skin shows a blue discoloration, likely from diagnostic marking or external staining. This image serves as an educational example of chronic inflammatory joint destruction and secondary ligamentous laxity leading to fixed musculoskeletal deformities in systemic autoimmune conditions.

This composite figure displays clinical and multi-modality imaging findings of a patient with Rheumatoid Arthritis (RA) and striatal hand deformity. Panels A and B are clinical photographs showing significant swelling of the proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints, with a rigid, flexed deformity of the right wrist resembling bony ankylosis. Panel C is a posteroanterior hand radiograph demonstrating periarticular osteopenia, radiocarpal joint space narrowing, and flexion of the index finger distal interphalangeal (DIP) joint. Panel D provides a 3D CT reconstruction that clearly visualizes a dorsal dislocation of the distal ulnar joint and spatial misalignment of the carpal bones without true osseous bridging. Panels E and F show post-treatment clinical and radiographic follow-up, respectively, highlighting a marked reduction in soft tissue swelling of the hand and improved joint alignment and bone density. The collection illustrates the differentiation between fixed dystonic deformities and active inflammatory arthropathy in a rheumatological context, emphasizing the importance of cross-sectional imaging (CT) over 2D radiography for assessing complex joint architecture.

This composite figure displays clinical and multi-modality imaging findings of a patient with Rheumatoid Arthritis (RA) and striatal hand deformity. Panels A and B are clinical photographs showing significant swelling of the proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints, with a rigid, flexed deformity of the right wrist resembling bony ankylosis. Panel C is a posteroanterior hand radiograph demonstrating periarticular osteopenia, radiocarpal joint space narrowing, and flexion of the index finger distal interphalangeal (DIP) joint. Panel D provides a 3D CT reconstruction that clearly visualizes a dorsal dislocation of the distal ulnar joint and spatial misalignment of the carpal bones without true osseous bridging. Panels E and F show post-treatment clinical and radiographic follow-up, respectively, highlighting a marked reduction in soft tissue swelling of the hand and improved joint alignment and bone density. The collection illustrates the differentiation between fixed dystonic deformities and active inflammatory arthropathy in a rheumatological context, emphasizing the importance of cross-sectional imaging (CT) over 2D radiography for assessing complex joint architecture.

Searching PubMed

"rheumatoid arthritis"[MeSH Terms] AND "treatment"[MeSH Terms]

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Finding Sources
Reading File
Reading File
I now have comprehensive information from top-tier sources. Let me compose the full answer.

Rheumatoid Arthritis (RA)

Rheumatoid arthritis is a chronic, systemic autoimmune disease that primarily causes a nonsuppurative proliferative and inflammatory synovitis, often progressing to destruction of articular cartilage and joint fusion (ankylosis). It is three times more common in women and peaks in incidence in the 3rd to 5th decades.
- Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine

Pathogenesis

RA Pathogenesis Diagram - Pannus, osteoclast, cartilage and bone destruction
RA develops from a convergence of genetic susceptibility and environmental triggers:

Genetic Factors

  • ~50% of RA risk is inherited
  • HLA-DR4 is strongly associated with ACPA-positive RA
  • The shared epitope hypothesis: a citrullinated protein (vinculin) mimics microbial epitopes that are presented by HLA-DR4 (molecular mimicry)

Environmental Triggers

  • Smoking and periodontitis are the best-documented environmental risk factors
  • These promote enzymatic citrullination of self-proteins (arginine → citrulline), creating neo-epitopes that break immune tolerance

Immune Cascade

  1. CD4+ Th1 and Th17 cells react against citrullinated joint antigens
  2. Cytokine storm: TNF-α, IL-1, IL-6 from macrophages recruit leukocytes and stimulate proteases that destroy cartilage
  3. IL-17 from Th17 cells recruits neutrophils and monocytes
  4. RANKL expressed on T cells activates osteoclasts → bone erosion
  5. B cells and plasma cells produce:
    • Rheumatoid factor (RF): IgM/IgA autoantibody against Fc portion of IgG
    • Anti-citrullinated protein antibodies (ACPAs): more specific for RA

The Role of Fibroblast-like Synoviocytes (FLS)

FLS are partially transformed cells that lose contact inhibition and release MMPs (MMP1, MMP3, MMP13) in excess over inhibitors (TIMPs). They drive the cartilage-pannus junction - the anatomical site of joint destruction. Osteoclasts localize in periarticular bone driven by RANKL, IL-1, TNF, and IL-17.
- Robbins & Kumar Basic Pathology, p.792; Goldman-Cecil Medicine, p.2788

Morphology (What Happens in the Joint)

FeatureDetail
Synovial changesEdematous, thickened, hyperplastic synovium with delicate villi
HistologySynoviocyte hyperplasia; dense infiltrates of CD4+ T cells, B cells, plasma cells, macrophages; angiogenesis
PannusMass of edematous synovium + inflammatory cells + granulation tissue + fibroblasts that grows over and erodes articular cartilage
Bone erosionOsteoclast activation at pannus-bone interface; periarticular erosions and subchondral cysts
AnkylosisFibrous ankylosis → bony ankylosis in advanced disease
Rheumatoid nodulesNecrotizing granulomas in subcutaneous tissue (forearm, elbows, occiput)
- Robbins & Kumar Basic Pathology, p.792

Clinical Features

Joint Involvement

  • Onset: Gradual in ~50% of cases - weeks to months of malaise, fatigue, and generalized musculoskeletal pain before joint involvement
  • Pattern: Symmetric polyarthritis
  • Joints affected: MCPs, PIPs, wrists, ankles, elbows, knees - DIP joints are classically spared (distinguishes from OA and psoriatic arthritis)
  • Morning stiffness: >1 hour (hallmark; correlates with disease activity)
  • Joints are swollen, warm, painful, tender

Classic Hand Deformities (from tendon/ligament inflammation)

Rheumatoid arthritis hand deformities - ulnar deviation and swan-neck
  • Ulnar deviation at MCPs
  • Swan-neck deformity: PIP hyperextension + DIP flexion
  • Boutonniere deformity: PIP flexion + DIP hyperextension
  • Z-thumb (Hitchhiker's thumb): MCP flexion + IP hyperextension

Radiographic Hallmarks

  • Joint effusions
  • Juxta-articular osteopenia (periarticular bone loss)
  • Marginal erosions
  • Narrowing of joint space
  • Loss of articular cartilage
- Robbins & Kumar Basic Pathology, p.793

Extra-articular Manifestations

RA is a systemic disease. Circulating cytokines and immune complexes drive widespread comorbidities.
SystemManifestation
SkinRheumatoid nodules (20-30%), vasculitis
LungsInterstitial lung disease, pleural effusions, rheumatoid nodules
HeartPericarditis, accelerated atherosclerosis (major CV risk)
EyesSicca syndrome (secondary Sjögren's), episcleritis, scleritis
Blood vesselsVasculitis
SystemicFatigue, anemia of chronic disease, cognitive impairment, osteoporosis
Cervical spineAtlantoaxial subluxation (C1-C2) - risk of cord compression

Diagnosis

ACR/EULAR 2010 Classification Criteria

A score-based system - patients with a score ≥6/10 are classified as RA:
  • Joint involvement (0-5 points): number and size of affected joints
  • Serology (0-3 points): RF and/or ACPA positivity
  • Acute-phase reactants (0-1 point): elevated CRP or ESR
  • Duration of symptoms (0-1 point): ≥6 weeks

Key Lab Tests

TestSignificance
Anti-CCP (ACPA)Positive in 60-70% of RA; specificity 85-99%; may precede symptoms by years
Rheumatoid Factor (RF)Positive in ~80%; less specific (also positive in other conditions)
ESR / CRPElevated - markers of systemic inflammation
CBCNormocytic anemia of chronic disease; thrombocytosis
Synovial fluidInflammatory (WBC 5,000-50,000/µL, predominantly neutrophils)
Note: ~20% of RA patients are seronegative (RF and ACPA negative) - diagnosis is then clinical.

Treatment

Treatment follows a treat-to-target strategy: the goal is remission or low disease activity, with regular reassessment and escalation if the target is not met.

Step 1 - Conventional Synthetic DMARDs (csDMARDs)

  • Methotrexate (MTX) is the anchor drug and first-line DMARD for most patients
    • Titrated up to 25 mg/week; can be given subcutaneously for better bioavailability
    • Requires folic acid supplementation; monitor LFTs and CBC
  • Other csDMARDs: hydroxychloroquine, sulfasalazine, leflunomide
  • Triple therapy (MTX + HCQ + SSZ) is an alternative to biologics

Step 2 - Biologic DMARDs (bDMARDs)

Used when csDMARDs fail to achieve target; most effective when combined with MTX:
ClassDrugsTarget
TNF inhibitorsEtanercept, infliximab, adalimumab, certolizumab, golimumabTNF-α
IL-6 inhibitorTocilizumab, sarilumabIL-6 receptor
Costimulation blockerAbataceptCD80/CD86 (T cell activation)
B cell depletionRituximabCD20 on B cells
IL-1 inhibitorAnakinraIL-1 receptor

Step 3 - Targeted Synthetic DMARDs (tsDMARDs)

  • JAK inhibitors: Tofacitinib, baricitinib, upadacitinib
  • Oral agents; inhibit intracellular JAK-STAT signaling
  • Carry FDA warnings for thrombosis risk and cardiovascular events in high-risk patients

Adjunct Therapy

  • NSAIDs: Symptomatic relief only; never used without concurrent DMARDs
  • Glucocorticoids: Rapidly effective bridge therapy; should be tapered and eventually discontinued ("best dose for chronic use is zero")
  • Physical therapy and occupational therapy
  • Surgery: Joint replacement (hip, knee) for end-stage disease; synovectomy in selected cases
- Firestein & Kelley's Textbook of Rheumatology; Goldman-Cecil Medicine

Prognosis

  • With early diagnosis and treat-to-target strategy, most patients can achieve remission or low disease activity
  • Poor prognostic factors: high ACPA/RF titers, high CRP/ESR, many swollen joints, early radiographic erosions, smoking
  • Long-term anti-TNF therapy increases risk of opportunistic infections (especially reactivation TB - screen before starting)
  • Cardiovascular disease is the leading cause of excess mortality in RA - aggressive CV risk factor management is essential
- Firestein & Kelley's Textbook of Rheumatology; Robbins & Kumar Basic Pathology

Rheumatic arthritis

The previous response already covered Rheumatoid Arthritis comprehensively. Here's a concise summary of the key points:

Rheumatoid Arthritis (RA) - Summary

What It Is

A chronic systemic autoimmune disease causing inflammatory synovitis, cartilage destruction, and joint erosion. Prevalence ~0.5-1%; 3x more common in women; peak onset 3rd-5th decade.

Pathogenesis (in brief)

RA Pathogenesis - pannus, osteoclasts, cartilage destruction
  • Trigger: Smoking/infection causes citrullination of self-proteins → immune tolerance breaks down
  • Genetics: HLA-DR4 association; ~50% genetic risk
  • Key cells: CD4+ T cells, B cells, macrophages, fibroblast-like synoviocytes
  • Key cytokines: TNF-α, IL-1, IL-6, IL-17
  • Result: Pannus formation → cartilage erosion + bone destruction via osteoclasts (RANKL-driven)

Clinical Features

Joint pattern: Symmetric polyarthritis - MCPs, PIPs, wrists (DIP joints spared)
Morning stiffness >1 hour - hallmark
Classic deformities:
Rheumatoid arthritis hand - ulnar deviation and swan-neck deformity
DeformityDescription
Ulnar deviationFingers deviate toward ulnar side at MCPs
Swan-neckPIP hyperextension + DIP flexion
BoutonnierePIP flexion + DIP hyperextension
Z-thumbMCP flexion + IP hyperextension
Extra-articular: Rheumatoid nodules, ILD, pericarditis, scleritis, atlantoaxial subluxation, accelerated atherosclerosis

Diagnosis

TestFinding
Anti-CCP (ACPA)Positive in 60-70%; specificity 85-99%
Rheumatoid Factor (RF)Positive in ~80%; less specific
ESR/CRPElevated
X-rayMarginal erosions, juxta-articular osteopenia, joint space narrowing
~20% of patients are seronegative - diagnosed clinically.
ACR/EULAR 2010 Criteria (score ≥6/10): based on joint count, serology, acute-phase reactants, and duration ≥6 weeks.

Treatment (Treat-to-Target: aim for remission or low disease activity)

StepDrugs
1st lineMethotrexate (MTX) - anchor DMARD, up to 25mg/week ± folic acid
Add-on csDMARDsHydroxychloroquine, sulfasalazine, leflunomide
Biologic DMARDsTNF inhibitors (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), rituximab, abatacept
JAK inhibitorsTofacitinib, baricitinib, upadacitinib (oral targeted therapy)
Bridge therapyShort-course glucocorticoids (taper ASAP)
Symptom reliefNSAIDs (never alone - always with DMARDs)
Screen for TB before starting biologics. Monitor cardiovascular risk throughout.

If you'd like me to go deeper into any specific aspect - such as diagnosis criteria, a particular drug class, extra-articular features, or RA in special populations (pregnancy, elderly) - just ask.
This is a shared conversation. Sign in to Orris to start your own chat.